Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Vaccibody AS
Oslo Research Park
Gaustadalléen 21
Oslo, 0349, NOR

People

Chief Executive Officer

Funding

TOTAL $3.49M
FUNDING TOTAL $3.49M
Grant, 11/2012
Norwegian Research Council
€2M
Seed, 6/2013
€733k

Tags

Vaccibody

Vaccibody AS was established 2007 as a spin-off from the University of Oslo and Oslo University hospital. The Vaccibody technology was conceived in the laboratory of Professor Bjarne Bogen, one of Europe’s leading immunologists. With Professor Inger Sandlie and Agnete Fredriksen he invented the basic construct of a novel vaccine molecule, and impressive preclinical results in animal studies was demonstrated. All rights to the technology was assigned to Vaccibody at the company establishment.

With funding from The Norwegian Research Council , Innovation Norway, and private investors, the company has established the proof of concept for the vaccine platform. Vaccibody has now started the development of an immuntherapy against HPV-induced malignancies, such as precanceous lesions of cervical cancer.

Recent Milestones

Videos

Screenshots

Vaccibody screenshot
Above: Home Page
Uploaded: 6/26/13

Sources

  1. Vaccibody Receives Euros 2 Million to Develop Therapeutic Cervical Cancer Vaccine (businesswire.com) [edit]
  2. Vaccibody raised 733.000 € (vaccibody.com) [edit]
Edit This Page
Last Edited 12/10/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy